Sino Biological and Ainnocence Partner to Offer Next-Generation CRO Antibody Development Services

28.03.2022 - Beijing, China, March 28, 2022 (GLOBE NEWSWIRE) - via NewMediaWire - Sino Biological, Inc.(“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which ...

Related Keywords

Lurong Pan ,Rob Burgess , ,Sino Biological ,Chief Business Officer ,Private Securities Litigation Reform ,